Aziyo Biologics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aziyo Biologics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4% to $49,187,000. Profit margin reached -67%. Total operating expenses were $45,762,000.
Profit Margin
| 2018 | 39.03M | -11.56M | -29.63% |
|---|---|---|---|
| 2019 | 42.90M | -11.93M | -27.83% |
| 2020 | 42.68M | -21.82M | -51.13% |
| 2021 | 47.39M | -24.83M | -52.4% |
| 2022 | 49.18M | -32.89M | -66.88% |
AZYO Income Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 49.18M | 47.39M | 42.68M | 42.90M | 39.03M |
Cost of revenue | 29.96M | 28.36M | 22.12M | 23.13M | 23.09M |
Gross profit | 19.22M | 19.02M | 20.56M | 19.76M | 15.94M |
Operating exp. | |||||
Research and development | 8.94M | 9.26M | 4.08M | 2.4M | 2.48M |
Selling and marketing | 20.19M | 18.82M | 16.84M | 16.16M | 13.16M |
Total operating expenses | 45.76M | 42.05M | 34.16M | 28.17M | 24.16M |
Operating income | -26.54M | -23.03M | -13.59M | -8.40M | -8.22M |
Other income (expenses), net | -6.32M | -1.74M | -8.2M | -3.5M | 2.2M |
Income before tax | -32.86M | -24.77M | -21.79M | -11.90M | -11.54M |
Income tax expense | 34K | 55K | 26K | 30K | 26K |
Net income | -32.89M | -24.83M | -21.82M | -11.93M | -11.56M |
Earnings per share | |||||
Basic EPS | -2.38 | -2.38 | -7.65 | -1.82 | -1.83 |
Diluted EPS | -2.38 | -2.38 | -7.65 | -1.82 | -1.83 |
| Data source | Data source | Data source |